- Your selection
- Clear all
- Biotechnology x
- English x
- Europe x
4 case(s) found.
Kusha Ahmad is tasked with facilitating headcount reduction following the acquisition of the Societe Francaise de Biotechnologie (SFB) by Big American Pharmaceuticals (BAP), and the subsequent closure of the SFB office in Lyon, France. In accordance with regulations introduced in 2017, staff are entitled to a “rupture conventionnelle collective”.
Reference 6684
Published 15 Nov 2021
Length 4 page(s)
Region Europe
Industry Biotechnology
Kusha Ahmad is tasked with facilitating headcount reduction following the acquisition of the Societe Francaise de Biotechnologie (SFB) by Big American Pharmaceuticals (BAP), and the subsequent closure of the SFB office in Lyon, France. In accordance with regulations introduced in 2017, staff are entitled to a “rupture conventionnelle collective”.
Kusha Ahmad is tasked with facilitating headcount reduction following the acquisition of the Societe Francaise de Biotechnologie (SFB) by Big American Pharmaceuticals (BAP), and the subsequent closure of the SFB office in Lyon, France. In accordance with regulations introduced in 2017, staff are entitled to a “rupture conventionnelle collective”.
Reference 6684
Published 15 Nov 2021
Length 2 page(s)
Region Europe
Industry Biotechnology
Kusha Ahmad is tasked with facilitating headcount reduction following the acquisition of the Societe Francaise de Biotechnologie (SFB) by Big American Pharmaceuticals (BAP), and the subsequent closure of the SFB office in Lyon, France. In accordance with regulations introduced in 2017, staff are entitled to a “rupture conventionnelle collective”.
Set in 2014, this case study examines the development and ongoing transition to value- and outcomes-based commissioning for diabetes care across North Central London (NCL). With the aim of improving health outcomes among their local populations, Clinical Commissioning Groups (CCGs) in NCL set out to transform the delivery and funding of services.
Reference 6120
Published 23 Nov 2015
Length 28 page(s)
Topic Operations
Region Europe
Industry Biotechnology
Set in 2014, this case study examines the development and ongoing transition to value- and outcomes-based commissioning for diabetes care across North Central London (NCL). With the aim of improving health outcomes among their local populations, Clinical Commissioning Groups (CCGs) in NCL set out to transform the delivery and funding of services.
Business has traditionally enjoyed a pre-eminent position in the Swiss political economy. This case looks at political conflicts over chemicals and biotechnology regulation and Swiss entry into the European Economic Area, showing how the growing environmentalist movements have challenged this position and that important changes in the Swiss political economy may be imminent.
Reference 4222
Published 01 Jan 1993
Length 22 page(s)
Topic Economics & Finance
Region Europe
Industry Pharmaceuticals, Biotechnology, Chemicals
Business has traditionally enjoyed a pre-eminent position in the Swiss political economy. This case looks at political conflicts over chemicals and biotechnology regulation and Swiss entry into the European Economic Area, showing how the growing environmentalist movements have challenged this position and that important changes in the Swiss political economy may be imminent.